Expertise in
4
conditions

Keith W. Muir

University Avenue, 
Glasgow, SCT, GB 
Expertise in
4
conditions
University Avenue, 
Glasgow, SCT, GB 

Overview

Keith Muir practices practicing medicine in Glasgow, United Kingdom.

Mr. Muir is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Stroke, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, Transient Ischemic Attack (TIA), Vascular Dementia, and Thrombectomy.

He is actively involved in clinical research, co-authoring 280 peer reviewed articles and participating in 8 clinical trials.

Gender

Male

Locations

University Avenue, Glasgow, SCT, United Kingdom
Other Locations
Western Infirmary
Glasgow, SCT, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
Enrollment Status: Completed
Publish Date: September 01, 2026
Intervention Type: Drug, Other
Study Drug: Edoxaban
Study Phase: Phase 4
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Substudies: MRI, Cognitive
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Substudies: MRI, Cognitive
Enrollment Status: Completed
Publish Date: September 12, 2025
Intervention Type: Drug
Study Drugs: Telmisartan, Amlodipine, Indapamide
Study Phase: Phase 3
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Tenecteplase, Antiplatelet Monotherapy
Study Phase: Phase 3
Prevention of Hypertensive Injury to the Brain by Intensive Treatment of Blood Pressure After Intracerebral Haemorrhage
Prevention of Hypertensive Injury to the Brain by Intensive Treatment of Blood Pressure After Intracerebral Haemorrhage
Enrollment Status: Terminated
Publish Date: December 10, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Prospective International Multicentre Randomised Controlled Single Blind Clinical Investigation of Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS)
A Prospective International Multicentre Randomised Controlled Single Blind Clinical Investigation of Magnetically Enhanced Diffusion for Acute Ischaemic Stroke (MEDIS)
Enrollment Status: Suspended
Publish Date: January 28, 2019
Intervention Type: Device
Study Phase: Not Applicable
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Enrollment Status: Terminated
Publish Date: December 04, 2018
Intervention Type: Drug
Study Phase: Phase 3
Penumbra and Recanalisation Acute Computed Tomography in Ischaemic Stroke Evaluation
Penumbra and Recanalisation Acute Computed Tomography in Ischaemic Stroke Evaluation
Enrollment Status: Unknown
Publish Date: August 03, 2018
Intervention Type: Other
Study Phase: Not Applicable
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis - Pilot Phase (ATTEST)
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis - Pilot Phase (ATTEST)
Enrollment Status: Completed
Publish Date: August 03, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

280 Total Publications

Proposed Corrections to the 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke.
Proposed Corrections to the 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke.
Journal: Stroke
Published: July 31, 2026

Frequently Asked Questions about Keith W. Muir

Is Keith W. Muir a top-rated expert for Stroke?

MediFind is an objective health platform that identifies experts based on real-world data. Keith W. Muir is classified as an Elite expert for Stroke, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Keith W. Muir participate in research or clinical trials?

Yes. Keith W. Muir has published 280 articles and abstracts on conditions like Stroke. You can view a list of Keith W. Muir's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Muir's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile